Hodgkin’s Lymphoma Treatment Adapted after Interim PET-CT

Patients with advanced Hodgkin’s are often treated with one of two chemotherapy regimens associated with similar survival but different toxicities. Could escalating or de-escalating therapy according to interim PET findings improve outcomes? New research findings are summarized in a new NEJM Quick Take video. Learn more at http://nej.md/1WoeHdF